These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 37771431)
1. Progress in investigating the relationship between Schlafen5 genes and malignant tumors. Tu T; Yuan Y; Liu X; Liang X; Yang X; Yang Y Front Oncol; 2023; 13():1248825. PubMed ID: 37771431 [TBL] [Abstract][Full Text] [Related]
2. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y Front Immunol; 2022; 13():922138. PubMed ID: 36090985 [TBL] [Abstract][Full Text] [Related]
3. Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells. Katsoulidis E; Mavrommatis E; Woodard J; Shields MA; Sassano A; Carayol N; Sawicki KT; Munshi HG; Platanias LC J Biol Chem; 2010 Dec; 285(51):40333-41. PubMed ID: 20956525 [TBL] [Abstract][Full Text] [Related]
5. Human Schlafen 5 (SLFN5) Is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells. Sassano A; Mavrommatis E; Arslan AD; Kroczynska B; Beauchamp EM; Khuon S; Chew TL; Green KJ; Munshi HG; Verma AK; Platanias LC Mol Cell Biol; 2015 Aug; 35(15):2684-98. PubMed ID: 26012550 [TBL] [Abstract][Full Text] [Related]
6. Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumption. Vit G; Hirth A; Neugebauer N; Kraft BN; Sigismondo G; Cazzola A; Tessmer C; Duro J; Krijgsveld J; Hofmann I; Berger M; Klüter H; Niehrs C; Nilsson J; Krämer A Cell Death Discov; 2022 Dec; 8(1):484. PubMed ID: 36477080 [TBL] [Abstract][Full Text] [Related]
7. Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma. Arslan AD; Sassano A; Saleiro D; Lisowski P; Kosciuczuk EM; Fischietti M; Eckerdt F; Fish EN; Platanias LC Oncogene; 2017 Oct; 36(43):6006-6019. PubMed ID: 28671669 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of SLFN5 induced the epithelial-mesenchymal transition in human lung cancer cell line A549 through β-catenin/Snail/E-cadherin pathway. Guo L; Liu Z; Tang X Eur J Pharmacol; 2019 Nov; 862():172630. PubMed ID: 31472120 [TBL] [Abstract][Full Text] [Related]
9. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer. Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393 [TBL] [Abstract][Full Text] [Related]
10. The Long Noncoding RNA MEG3 Retains Epithelial-Mesenchymal Transition by Sponging miR-146b-5p to Regulate SLFN5 Expression in Breast Cancer Cells. Gu X; Li J; Zuo X; Chen K; Wan G; Deng LL; Zhao W; Lu C J Immunol Res; 2022; 2022():1824166. PubMed ID: 36033389 [TBL] [Abstract][Full Text] [Related]
11. The Schlafen family: complex roles in different cell types and virus replication. Liu F; Zhou P; Wang Q; Zhang M; Li D Cell Biol Int; 2018 Jan; 42(1):2-8. PubMed ID: 28460425 [TBL] [Abstract][Full Text] [Related]
12. Human Schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription. Wan G; Zhu J; Gu X; Yang Y; Liu Y; Wang Z; Zhao Y; Wu H; Huang G; Lu C Br J Cancer; 2020 Aug; 123(4):633-643. PubMed ID: 32488136 [TBL] [Abstract][Full Text] [Related]
13. Progress of SLFN family proteins in tumor and virus infection. Chen SM; Ma L; Cen S Yi Chuan; 2020 May; 42(5):444-451. PubMed ID: 32431296 [TBL] [Abstract][Full Text] [Related]
14. SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer. Xu QP; Deng K; Zhang Z; Shang H J Ovarian Res; 2023 Feb; 16(1):33. PubMed ID: 36747204 [TBL] [Abstract][Full Text] [Related]
15. Schlafen-5 inhibits LINE-1 retrotransposition. Ding J; Wang S; Liu Q; Duan Y; Cheng T; Ye Z; Cui Z; Zhang A; Liu Q; Zhang Z; Zhang N; Liu Q; An N; Zhao J; Yi D; Li Q; Wang J; Zhang Y; Ma L; Guo S; Wang J; Liang C; Zhou J; Cen S; Li X iScience; 2023 Oct; 26(10):107968. PubMed ID: 37810251 [TBL] [Abstract][Full Text] [Related]
16. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway. Wan G; Liu Y; Zhu J; Guo L; Li C; Yang Y; Gu X; Deng LL; Lu C Cell Signal; 2019 Jul; 59():1-12. PubMed ID: 30844429 [TBL] [Abstract][Full Text] [Related]
17. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Geserick P; Kaiser F; Klemm U; Kaufmann SH; Zerrahn J Int Immunol; 2004 Oct; 16(10):1535-48. PubMed ID: 15351786 [TBL] [Abstract][Full Text] [Related]
18. Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1. Brady G; Boggan L; Bowie A; O'Neill LA J Biol Chem; 2005 Sep; 280(35):30723-34. PubMed ID: 15946944 [TBL] [Abstract][Full Text] [Related]